PsiOxus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- PsiOxus Therapeutics's estimated annual revenue is currently $13.5M per year.
- PsiOxus Therapeutics's estimated revenue per employee is $155,000
- PsiOxus Therapeutics's total funding is $102.5M.
Employee Data
- PsiOxus Therapeutics has 87 Employees.
- PsiOxus Therapeutics grew their employee count by -29% last year.
PsiOxus Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Human Resources Director | Reveal Email/Phone |
2 | IT Manager | Reveal Email/Phone |
3 | Analytical Development Scientist | Reveal Email/Phone |
4 | Scientist II and Laboratory Supervisor | Reveal Email/Phone |
5 | Associate Scientist | Reveal Email/Phone |
PsiOxus Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is PsiOxus Therapeutics?
PsiOxus aims to be the world's leading cancer gene therapy company, delivering medicines of value to patients with cancer. We focus on discovering and developing innovative gene-based immuno-oncology treatments for solid tumors using our proprietary intravenously administered T-SIGn virus platform. Our portfolio of differentiated gene therapy products are all delivered systemically but act locally within the tumor. At PsiOxus we are advancing our internal early and clinical stage candidates and establishing strategic partnerships with immuno-oncology leaders to bring our cancer gene therapy products to patients. Find our more about us at www.psioxus.com
keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
$102.5M
Total Funding
87
Number of Employees
$13.5M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PsiOxus Therapeutics News
... Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma.
PsiOxus aims to lead the world in tumor re-engineering, delivering medicines of significant benefit to patients with cancer. We focus on...
The study assessed the effect of giving bluebird's anti-EGFR CAR-T cells in combination with vectors in development at PsiOxus Therapeutics.
... States),Oncolys BioPharma (Japan),BioVex (United States),Cell Genesys (United States),PsiOxus Therapeutics (United Kingdom),Shanghai ...
Other Companies in Abingdon
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $30.7M | 93 | 33% | N/A |
#2 | $33.5M | 95 | 30% | N/A |
#3 | $24.1M | 96 | -2% | N/A |
#4 | $15.1M | 104 | 24% | N/A |
#5 | $7.5M | 108 | N/A | N/A |